share_log

6-K: New Beyfortus data featured at IDWeek reinforce real-world effectiveness against RSV disease and hospitalization in infants and Sanofi in discussions to sell a controlling stake in Opella

6-K: New Beyfortus data featured at IDWeek reinforce real-world effectiveness against RSV disease and hospitalization in infants and Sanofi in discussions to sell a controlling stake in Opella

6-K:IDWeek上公布的Beyfortus新数据增强预防婴儿呼吸道合胞病毒疾病和住院治疗的实际效果以及赛诺菲安万特正在讨论出售Opella的控股权
美股SEC公告 ·  10/12 03:39
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息